drugset / Trial / NCT03995680
Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm
Phase 2
Completed
397 enrolled
Swiss Tropical & Public Health Institute
Public Health Laboratory Ivo de Carneri · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The rational of this study is to provide evidence on the safety and efficacy of a new chewable tablet of mebendazole compared to the standard tablet in preschool- and school-aged children infected with hookworm.
Timeline
- Start
- 2019-07-12
- Primary completion
- 2019-10-09
- Completion
- 2019-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mebendazole | Small molecule | — | Oral |